Molecular vaccines comprising antigen peptides and inflammatory cues make up a class of
therapeutics that promote immunity against cancer and pathogenic diseases but often …

Mass Spectrometry (MS) is becoming a preferred method to identify class I and class II
peptides presented on major histocompability complexes (MHC) on antigen presenting cells …

Cancer treatments that combine chemotherapy with immunotherapy are becoming
increasingly effective, but chemotherapy is generally considered to have …

The global pandemic of COVID-19 highlights the importance of vaccination, which remains
the most efficient measure against many diseases. Despite the progress in vaccine design …

Vaccine development efforts against HIV-1 have been hindered because of the high
mutation rate of the virus, and limitations for direct testing of HIV antigens in animal models …

Targeting dendritic cell-specific endocytic receptors using monoclonal antibodies fused to
desired antigens is an approach widely used in vaccine development to enhance the poor …

Multiple studies have been published emphasizing the significant role of nanoparticle (NP)
carriers in antigenic peptide-based subunit vaccines for the induction of potent humoral and …

Immunotherapy emerges as an effective avenue for tumor elimination and has many
advantages compared with traditional surgery, radiotherapy, and chemotherapy. Tumor …

Vaccines that can coordinately induce multi-epitope T cell–mediated immunity, T helper
functions, and immunologic memory may offer effective tools for cancer immunotherapy …

Vaccine carriers have been shown to enhance cytotoxic T lymphocyte (CTL) epitope peptide
vaccines by addressing intrinsic limitations of the vaccines. We have previously developed …